Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Musa Yilmaz

Showing results (41-50 of 160) with videos related to

Pageof 16
Sort By:
Peptides|September 28, 2014
A comprehensive immunohistochemical examination of the distribution of the fat-burning protein irisin in biological tissuesSuleyman Aydin, Tuncay Kuloglu, Suna Aydin, et al.
International Journal of Endocrinology|December 28, 2013
Acylated and desacylated ghrelin, preptin, leptin, and nesfatin-1 Peptide changes related to the body mass indexYusuf Ozkan, Esra Suay Timurkan, Suleyman Aydin, et al.
Blood Cancer Journal|September 19, 2024
Current status and research directions in acute myeloid leukemiaHagop Kantarjian, Gautam Borthakur, Naval Daver, et al.
Blood Advances|March 25, 2026
NGS-based measurable residual disease in long-term progression-free CLL survivors following FCR therapyAlexandre Bazinet, Alessandra Ferrajoli, Nitin Jain, et al.
Peptides|December 19, 2013
Cardiac, skeletal muscle and serum irisin responses to with or without water exercise in young and old male rats: cardiac muscle produces more irisin than skeletal muscleSuna Aydin, Tuncay Kuloglu, Suleyman Aydin, et al.
Peptides|September 25, 2013
Concentrations of preptin, salusins and hepcidins in plasma and milk of lactating women with or without gestational diabetes mellitusSuleyman Aydin, Onder Celik, Bilgin Gurates, et al.
Peptides|April 22, 2014
Decreased saliva/serum irisin concentrations in the acute myocardial infarction promising for being a new candidate biomarker for diagnosis of this pathologySuna Aydin, Suleyman Aydin, Mehmet Ali Kobat, et al.
British Journal of Haematology|May 9, 2024
Combination therapy with novel agents for acute myeloid leukaemia: Insights into treatment of a heterogenous diseaseWei-Ying Jen, Hagop Kantarjian, Tapan M Kadia, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 2, 2024
Outcome of Patients With Relapsed Acute Promyelocytic LeukemiaKoji Sasaki, Farhad Ravandi, Tapan Kadia, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 25, 2013
Similar outcome of patients with chronic myeloid leukemia treated with imatinib in or out of clinical trialsMusa Yilmaz, Hagop Kantarjian, Elias Jabbour, et al.
Pageof 16

Showing results (41-50 of 160) with videos related to

Sort By:
Pageof 16
Peptides|September 28, 2014
A comprehensive immunohistochemical examination of the distribution of the fat-burning protein irisin in biological tissuesSuleyman Aydin, Tuncay Kuloglu, Suna Aydin, et al.
International Journal of Endocrinology|December 28, 2013
Acylated and desacylated ghrelin, preptin, leptin, and nesfatin-1 Peptide changes related to the body mass indexYusuf Ozkan, Esra Suay Timurkan, Suleyman Aydin, et al.
Blood Cancer Journal|September 19, 2024
Current status and research directions in acute myeloid leukemiaHagop Kantarjian, Gautam Borthakur, Naval Daver, et al.
Blood Advances|March 25, 2026
NGS-based measurable residual disease in long-term progression-free CLL survivors following FCR therapyAlexandre Bazinet, Alessandra Ferrajoli, Nitin Jain, et al.
Peptides|December 19, 2013
Cardiac, skeletal muscle and serum irisin responses to with or without water exercise in young and old male rats: cardiac muscle produces more irisin than skeletal muscleSuna Aydin, Tuncay Kuloglu, Suleyman Aydin, et al.
Peptides|September 25, 2013
Concentrations of preptin, salusins and hepcidins in plasma and milk of lactating women with or without gestational diabetes mellitusSuleyman Aydin, Onder Celik, Bilgin Gurates, et al.
Peptides|April 22, 2014
Decreased saliva/serum irisin concentrations in the acute myocardial infarction promising for being a new candidate biomarker for diagnosis of this pathologySuna Aydin, Suleyman Aydin, Mehmet Ali Kobat, et al.
British Journal of Haematology|May 9, 2024
Combination therapy with novel agents for acute myeloid leukaemia: Insights into treatment of a heterogenous diseaseWei-Ying Jen, Hagop Kantarjian, Tapan M Kadia, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 2, 2024
Outcome of Patients With Relapsed Acute Promyelocytic LeukemiaKoji Sasaki, Farhad Ravandi, Tapan Kadia, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 25, 2013
Similar outcome of patients with chronic myeloid leukemia treated with imatinib in or out of clinical trialsMusa Yilmaz, Hagop Kantarjian, Elias Jabbour, et al.
Pageof 16